Company news
Faron Pharmaceuticals Oy news in 2020
Faron Pharmaceuticals Oy's news releases, calls and decks from 2020, newest first.
Faron's financial calendar for 2021
December 21, 2020
Presents at ESMO Immuno-Oncology Virtual Congress
December 10, 2020
To Participate in Upcoming Investor Conferences
November 23, 2020
Issue of Equity
November 20, 2020
First Results from WHO Solidarity Trial
October 16, 2020
Half-year Report
September 24, 2020
MATINS trial data presented at ESMO
September 18, 2020
Traumakine Update
August 18, 2020
Change of Adviser
July 27, 2020
Managers' transactions
July 8, 2020
Faron hosts virtual R&D Day today
June 16, 2020
Faron receives EUR 2.1 million funding from BF
June 15, 2020
Faron selected for EUR2.5 million grant from EIC
June 11, 2020
MATINS Update
June 1, 2020
Faron announces R&D Day to be held in June
May 28, 2020
Publication in Intensive Care Medicine
May 20, 2020
Faron receives grant from Business Finland
May 11, 2020
Clevegen manufacturing agreement
May 5, 2020
Traumakine to be a part of WHO's Solidarity trial
April 27, 2020
Update on results of Placing and issue of equity
April 23, 2020
Result of placing and issue price
April 22, 2020
Proposed Placing
April 21, 2020
AGM to be postponed
April 3, 2020
REMAP-CAP to study IFN beta-1a effect in COVID-19
April 1, 2020
Part 1 of the MATINS Phase I/II Study Completed
March 30, 2020
Correction to Faron´s Annual Report 2019
March 26, 2020
Faron´s Annual Report 2019 published
March 25, 2020
Final Results for the year ended December 31, 2019
March 20, 2020
FDA accepts protocol for new Traumakine trial
March 9, 2020
MATINS update
March 5, 2020
Faron to acquire AOC3 antagonist platform
March 2, 2020
Traumakine update
February 6, 2020
Ovarian cancer selected as 2nd MATINS trial cohort
January 27, 2020
DMC approves colorectal cancer cohort expansion
January 13, 2020
Decks in 2020
- Shareholder Meeting (May 2020)
Shareholder meeting · 25 slides · May 18, 2020
- FY2019 Earnings Presentation
Earnings · 26 slides · Mar 20, 2020